Ztlido is a lidocaine topical system designed for topical use [1]. The specific strength mentioned, 1.8%, refers to the concentration of lidocaine [1].
What is Ztlido used for?
Ztlido is indicated for the relief of postherpetic neuralgia, a type of nerve pain that can occur after shingles [1].
How does Ztlido work?
Lidocaine is a local anesthetic that works by blocking nerve signals in the pain-sending part of the body [2]. By temporarily blocking these signals, Ztlido can help to alleviate the sensation of pain [2]. The "topical system" refers to the delivery method, which is applied directly to the skin [1].
What is the typical dosage for Ztlido?
The Ztlido package contains four patches [3]. Each patch is 10 cm x 14 cm and contains 700 mg of lidocaine, which is equivalent to 1.8% lidocaine by weight [1]. The usual recommended dosage is to apply one patch to the affected painful area for up to 12 hours within a 24-hour period [1]. It is recommended to remove the patch before bathing or showering [1].
When does the patent for Ztlido expire?
Information on the specific patent expiration for Ztlido is available through resources like DrugPatentWatch.com [4]. Patents grant a period of market exclusivity, after which generic or biosimilar versions may become available.
Who makes Ztlido?
Ztlido is manufactured by Acorda Therapeutics, Inc [1].
What are the risks and side effects of Ztlido?
Common side effects reported with Ztlido include skin reactions at the application site, such as redness, rash, and itching [1]. Systemic adverse reactions, although rare, can occur if too much lidocaine is absorbed into the bloodstream. These can include lightheadedness, dizziness, blurred vision, and, in severe cases, seizures and cardiac arrest [1][2]. It is important to follow the prescribed dosage and application instructions to minimize these risks [1].
Can Ztlido be used for other types of pain?
While Ztlido is specifically approved for postherpetic neuralgia, healthcare providers may consider off-label uses based on their clinical judgment. However, its approved indication is limited to this specific condition [1].
What are alternatives to Ztlido for postherpetic neuralgia?
Other treatment options for postherpetic neuralgia may include other topical medications, oral pain medications (such as anticonvulsants or antidepressants), and nerve blocks [5]. The best treatment approach is determined by a healthcare professional based on the individual patient's condition and medical history [5].
How does Ztlido compare to other lidocaine patches?
Ztlido differs from some other lidocaine patches in its formulation and design, which may affect its adhesion and drug delivery characteristics [1]. For instance, it is a thin, flexible patch that adheres to the skin [1]. Patient experiences and efficacy can vary between different lidocaine patch products [1][5].
Sources:
[1] https://www.drugpatentwatch.com/drug/ztlido-lidocaine-topical-system
[2] https://www.drugpatentwatch.com/drug/lidocaine
[3] https://www.drugs.com/ztlido.html
[4] https://www.drugpatentwatch.com/
[5] https://www.ninds.nih.gov/health-information/disorders/postherpetic-neuralgia